文献速递前列腺癌

PSMA与氟昔洛韦转运体基因表达与原发性前列腺癌临床特征及分子亚型的关联

Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer.
PubMed 文献 · Eur Urol · 2021-04-08

结果显示PSMA表达与Gleason评分≥8、淋巴结转移及Decipher高风险正相关,而LAT2、LAT3和ASCT2表达与这些不良特征负相关;PSMA高表达与最差无转移生存相关,LAT3和ASCT2低表达亦与最差无转移生存相关。

要点

  • PSMA表达与Gleason评分≥8、淋巴结转移及高Decipher评分正相关。
  • LAT2、LAT3和ASCT2表达与Gleason评分≥8、淋巴结转移及高Decipher评分负相关。
  • PSMA最高十分位表达与最差无转移生存相关,LAT3和ASCT2最低十分位表达亦与最差无转移生存相关。

核心结论

  • PSMA基因表达与更差临床结局相关,而ASCT2、LAT2和LAT3基因表达与更好结局相关。

主要发现

  • PSMA及除一个外的所有氟昔洛韦转运体基因在前列腺癌中的表达高于良性组织。
  • PSMA表达与Gleason评分≥8和淋巴结转移相关,并与Decipher风险评分呈正线性相关。
  • LAT2、LAT3和ASCT2表达与Gleason评分≥8、淋巴结转移及高Decipher评分负相关。
  • PSMA表达最高十分位与最差无转移生存相关,LAT3和ASCT2表达最低十分位与最差无转移生存相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

18F-Fluciclovine-based positron emission tomography (PET) imaging is recommended in the USA for biochemical recurrence (BCR) after prostate cancer treatment. However, prostate-specific membrane antigen (PSMA)-based PET imaging is more common worldwide, supported by international guidelines, and is now approved by the Food and Drug Administration in the USA for initial staging of primary prostate cancer. Little is known about the molecular profiles of lesions detected by PSMA-targeted PET/computed tomography (CT) versus 18F-fluciclovine PET/CT. We examined the expression of PSMA (FOLH1) and the fluciclovine transporter genes LAT1-4 and ASCT1/2 in a combined cohort of more than 18 000 radical prostatectomy specimens and their associations with clinical outcomes. Expression of PSMA and all but one fluciclovine transporter gene was higher in prostate cancer than in benign tissue. PSMA expression was associated with Gleason score (GS) ≥8 and lymph node involvement (LNI), and had a positive linear correlation with Decipher risk score. By contrast, expression of the fluciclovine transporters LAT2, LAT3, and ASCT2 was negatively associated with GS ≥ 8, LNI, and high Decipher score. The top decile of PSMA expression was associated with poorest metastasis-free survival (MFS), while the bottom deciles of LAT3 and ASCT2 expression were associated with poorest MFS. PATIENT SUMMARY: We measured the expression of genes that encode the targets for two different radiotracers in PET (positron emission tomography) scans of the prostate. We found that PSMA gene expression (PSMA-based tracer) is associated with worse clinical outcomes, while expression of ASCT2, LAT2, and LAT3 genes (fluciclovine tracer) is associated with better outcomes.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Chu CE, Alshalalfa M, Sjöström M, et al. Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer. Eur Urol. 2021. PMID: 33840559. doi:10.1016/j.eururo.2021.03.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。